745771
Last Update Posted: 2009-03-20
Recruiting has ended
All Genders accepted | 18 Years-55 Years |
168 Estimated Participants | No Expanded Access |
Interventional Study | Accepts healthy volunteers |
Multiple Dose, Double-Blind, Placebo and Active Controlled Study of Pharmacokinetics of Diractin® as Well as Safety and Efficacy for the Treatment of Muscle Soreness
Multiple-dose, double-blind, double-dummy, parallel, randomized, placebo and active controlled study of pharmacokinetics of Diractin® as well as safety and efficacy for muscle soreness from exercise.
Eligibility
Relevant conditions:
Muscle Soreness
If you aren't sure if you meet the criteria above speak to your healthcare professional. Criteria may be updated but not reflected here, do not hesitate to contact the study if you think are close to fitting criteria.
locations
Data sourced from ClinicalTrials.gov